Safety of Topical Neuromodulators for the Treatment of Pruritus.
Department of Dermatology, MedStar Washington Hospital Center, Washington, DC2Department of Dermatology, MedStar Georgetown University Hospital, Washington, DC.
Michael A
MA
Cardis
Department of Dermatology, MedStar Washington Hospital Center, Washington, DC2Department of Dermatology, MedStar Georgetown University Hospital, Washington, DC.
Helena B
HB
Pasieka
D000287:Administration, Topical; D000369:Aged, 80 and over; D000639:Amitriptyline / Q000008:administration & dosage*; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage*; D008297:Male; D018377:Neurotransmitter Agents / Q000008:administration & dosage*; D011537:Pruritus / Q000175:diagnosis / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D016896:Treatment Outcome
D018712:Analgesics, Non-Narcotic; D004338:Drug Combinations; D018377:Neurotransmitter Agents; D000639:Amitriptyline; D007649:Ketamine